宫癌的保守治疗:一个单一的中心经历了二十年的时间
Guido M Rey Valzacchi1, Diego Odetto1, José M Saadi1
1Division of Gynecologic Oncology, Hospital Italiano of Buenos Aires, Buenos Aires, Argentina.
Gynecologic oncology reports
|June 26, 2023
概括
早期宫癌的节育手术提供了良好的生存率和怀孕率. laparoscopic 激进气管切除术显示复发率高于开放激进气管切除术,尽管瘤大小对复发的影响更大.
科学领域:
- 妇科瘤学 妇科瘤学
- 生殖医学 生殖医学
- 手术瘤学手术瘤学
背景情况:
- 节育治疗对于被诊断患有早期宫癌的年轻女性来说至关重要.
- 维持生育能力的外科手术技术正在不断发展.
- 了解瘤和产科结果对于患者咨询至关重要.
研究的目的:
- 评估各种节育手术技术的外科,瘤和产科结果.
- 为了比较早期宫癌的不同手术方法之间的结果.
- 提供数据,对正在进行的关于节育治疗的讨论进行批判性分析.
主要方法:
- 对48名患有FIGO 2009阶段IA2-IB1宫癌的患者进行了回顾性分析,这些患者接受了节育手术 (2004-2020年).
- 手术技术包括化与骨盆淋巴结评估,开放式激光通道切除术和腹腔镜激光通道切除术.
- 收集了关于并发症,无病生存率 (DFS),总生存率 (OS) 和怀孕/活产率的数据.
主要成果:
- 五年无病生存率为89%,五年总生存率为96%.
- 晚期术后并发症发生在31.2%的患者中,最常见的是宫狭窄症.
- 怀孕和活产率分别为41.4%和88.2%. 腹腔镜组的复发率高于腹腔镜组 (22.7%) 与开放组 (4.8%),瘤大小是复发的重要因素.
结论:
- 早期宫癌的节育性手术显示出良好的瘤和产科结果.
- 虽然像宫狭窄症这样的并发症可能会发生,但它们是可以控制的.
- 瘤大小是复发风险的一个关键因素,比手术本身更重要.
相关概念视频
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:30Cancer Vaccines
433
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
433
02:49Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
01:21Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K